分子生物学用酵素・キット・試薬の世界市場動向および予測（～2021年）...市場調査レポートについてご紹介

1 Molecular Biology Kits Market: Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Molecular Biology Kits Market: Research Methodology (Page No. – 20)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Research Design
2.5 Market Data Validation and Triangulation
2.6 Assumptions for the Study

3 Molecular Biology Kits Market: Executive Summary (Page No. – 30)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 34)
4.1 Molecular Biology Enzymes and Kits & Reagents: Market Overview (2016-2021)
4.2 Geographic Analysis: Molecular Biology Enzymes and Kits & Reagents Market, By End User
4.3 Molecular Biology Enzymes and Kits & Reagents Market, By Product
4.4 Molecular Biology Enzymes and Kits & Reagents Market, By Application
4.5 Molecular Biology Enzymes and Kits & Reagents Market, By End User
4.6 Geographic Snapshot of the Molecular Biology Enzymes and Kits & Reagents Market

5 Molecular Biology Kits Market: Market Overview (Page No. – 38)
5.1 Introduction
5.1.1 Drivers
5.1.1.1 Technological Advancements in the Life Sciences Industry
5.1.1.2 Increased Research Activities in the Pharmaceutical and Biotechnology Sectors
5.1.1.3 Rising Incidence of Infectious Diseases and Genetic Disorders
5.1.1.4 Successful Completion of the Human Genome Project
5.1.2 Restraints
5.1.2.1 Privacy Issues Related to Genetic Information
5.1.2.2 Unfavorable Reimbursement Scenario for Genetic Testing
5.1.3 Opportunities
5.1.3.1 Increased Use of Personalized Medicine
5.1.3.2 Developing Countries Present Significant Opportunities for the Molecular Biology Enzymes and Kits & Reagents Market
5.1.3.3 Shift From Plant-Derived to Genome-Based Drug Discovery

6 Industry Insights (Page No. – 46)
6.1 Porter’s Five Forces Analysis
6.1.1 Bargaining Power of Buyers
6.1.2 Bargaining Power of Suppliers
6.1.3 Threat From New Entrants
6.1.4 Threat of Substitutes
6.1.5 Intensity of Competitive Rivalry

7 Global Molecular Biology Enzymes and Kits & Reagents Market, By Product (Page No. – 49)
7.1 Introduction
7.2 Kits and Reagents
7.3 Enzymes
7.3.1 Polymerases
7.3.2 Ligases
7.3.3 Restriction Endonucleases
7.3.4 Reverse Transcriptases
7.3.5 Phosphatases
7.3.6 Proteases and Proteinases
7.3.7 Other Enzymes

8 Global Molecular Biology Enzymes and Kits & Reagents Market, By Application (Page No. – 57)
8.1 Introduction
8.2 Polymerase Chain Reaction (PCR)
8.3 Sequencing
8.4 Cloning
8.5 Epigenetics
8.6 Restriction Digestion
8.7 Synthetic Biology
8.8 Other Applications

9 Molecular Biology Enzymes and Kits & Reagents Market, By End User (Page No. – 66)
9.1 Introduction
9.2 Academic & Research Institutes
9.3 Hospitals & Diagnostic Centers
9.4 Pharmaceutical & Biotechnology Companies
9.5 Other End Users

10 Molecular Biology Enzymes and Kits & Reagents Market, By Region (Page No. – 73)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Increasing Research Funding for Genomics Research
10.2.1.2 Rising Number of Pharmaceutical and Biotechnology Companies Likely to Boost Sales of Molecular Biology Enzymes, Kits, Reagents
10.2.1.3 Increasing Prevalence of Conditions Involving Molecular Diagnostics, Backed By Reimbursement
10.2.2 Canada
10.2.2.1 Investments in Research Projects
10.3 Europe
10.3.1 Germany
10.3.1.1 Presence of A Large Number of Academic and Research Institutes
10.3.1.2 Venture Capital Investments in Germany
10.3.2 U.K.
10.3.2.1 Funding for Research Activities
10.3.2.2 Increasing Adoption of Molecular Diagnostics for Cancer Diagnosis in the U.K.
10.3.3 France
10.3.3.1 Presence of Large Patient Pool for Cancer
10.3.4 RoE
10.3.4.1 Presence of Large Number of Pharmaceutical and Biotechnology Companies
10.4 Asia-Pacific
10.4.1 China
10.4.1.1 Increasing Government Interest in Biomedical and Biotechnology Industries
10.4.1.2 Presence of Bio-Clusters in China
10.4.1.3 Outsourcing of Clinical Research Activities to China
10.4.2 Japan
10.4.2.1 Conferences and Meetings to Propel the Japanese Market
10.4.2.2 Rising Research Funding and Growing Geriatric Population
10.4.3 India
10.4.3.1 Growing Pharmaceutical Industry in India Backed By Government Initiatives to Drive The Growth for Molecular Biology Kits Market
10.4.3.2 Development of Bio-Clusters to Propel the Biotechnology Industry in India
10.4.4 Roapac
10.4.4.1 Korea-U.S. Free Trade Agreement (Korus)
10.4.4.2 Initiatives By Non-Profit Organizations
10.4.4.3 Alliances and Partnerships in Molecular Biology Application Areas to Boost Australian Molecular Biology Kits Market

10.5 Rest of the World (RoW)
10.5.1 Latin America
10.5.1.1 Investments in Research & Innovation Centers and Conferences & Workshops in Brazil
10.5.2 Middle East and Africa
10.5.2.1 Rising Prevalence of Conditions Involving Molecular Diagnostics in Africa
10.5.2.2 Conferences in the Middle East and Africa

11 Competitive Landscape (Page No. – 121)
11.1 Overview
11.2 Market Share Analysis
11.2.1 Introduction
11.2.2 Thermo Fisher Scientific, Inc.
11.2.3 Merck KGAA
11.2.4 Others
11.3 Competitive Situation and Trends
11.3.1 New Product Launches
11.3.2 Agreements, Alliances, Partnerships and Collaboration
11.3.3 Acquisitions
11.3.4 Expansions
11.3.5 Others

12 Company Profiles (Page No. – 129)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 Thermo Fisher Scientific, Inc.
12.3 Merck KGAA
12.4 Promega Corporation
12.5 New England Biolabs, Inc.
12.6 Illumina, Inc.
12.7 Takara Bio Inc.
12.8 Qiagen N.V.
12.9 Agilent Technologies, Inc.
12.10 F. Hoffmann-La Roche Ltd
12.11 Becton, Dickinson and Company

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 162)
13.1 Discussion Guide
13.2 Company Developments (2013-2016)
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customization
13.6 Related Reports